Tuesday, June 18, 2024

Surgical Practices to be Transformed as Moon Surgical’s Maestro System Gains FDA Clearance

Similar articles

Moon Surgical, a French-American pioneer in surgical innovation, has received the U.S. Food and Drug Administration (FDA) clearance for the commercial version of its Maestro System for enhancing surgical practices. This clearance allows the company to deploy the Maestro System in the US and Europe in a Limited Market Release, ahead of a broader launch in 2025. This significant milestone marks a major step forward for Moon Surgical, reflecting the company’s commitment to enhancing surgical practices and patient outcomes globally.

The Maestro Digital Surgical Assistant by Moon Surgical is set to revolutionize the broad laparoscopy market. “At Moon Surgical, we are innovating and inspiring the art of surgery,” said Anne Osdoit, CEO of Moon Surgical. The Maestro System introduces a new category of robotic surgery, enhancing existing tools and optimizing surgical services with data-driven insights.

This innovative system supports surgeons, operating room staff, and patients in the 18.8 million annual soft tissue surgical practices not currently supported by available telerobotic systems. Its small, adaptable design integrates seamlessly into existing clinical workflows for any laparoscopic indication, boosting operating room efficiency and providing shorter, more predictable procedure durations.

Surgical Practices Enhanced by AI-Powered Maestro System for Better Patient Outcomes

Equipped with NVIDIA Holoscan, the Maestro System uses a powerful edge computing platform that allows real-time algorithms based on artificial intelligence to be deployed in the operating room. This capability provides immediate benefits during surgery, enhancing the overall surgical experience and offering significant improvements in patient outcomes. The system’s advanced features ensure that surgeons can perform procedures with greater precision and confidence, ultimately leading to better healthcare delivery.

“The team at Moon Surgical has been impressively delivering on schedule while adding resources to get ready for its commercial phase,” commented Fred Moll, Chair of the Moon Surgical board. “After a fantastic initial experience in Europe in a real-world, multi-specialty setting, we are eager to implement Maestro programs at select US sites over the next few months.” This statement highlights the company’s readiness and enthusiasm for expanding its reach and impact in the surgical field.

Moon Surgical’s Maestro System obtained the CE mark in September 2023 and has already been used to treat over 200 patients in general, bariatric, and gynecologic surgery at two European pilot sites. This real-world, multi-specialty experience underscores the system’s versatility and effectiveness, demonstrating its potential to significantly improve surgical outcomes across various medical disciplines. The positive feedback and successful results from these initial uses provide a strong foundation for the system’s future implementation and broader adoption.

Surgical Practices

Moon Surgical’s Innovations Transform Surgical Practices with Digital Efficiency and Sustainability

Moon Surgical, based in Paris, France, and San Francisco, California, is building the OR of the future—one that is digitalized, efficient, and sustainable. The combined power of the transformative Maestro System and the intelligent Maestro Insights empowers healthcare teams to make confident decisions and provide better surgical care for their patients. This forward-thinking approach ensures that the company remains at the forefront of surgical innovation, continuously advancing the capabilities and benefits of its technologies.

Founded in 2020, Moon Surgical prioritizes innovation, inclusivity, creativity, and collaboration among its multi-cultural team members. The company’s commitment to transforming the surgical landscape is evident in its continuous development and successful implementation of groundbreaking technologies. By fostering an environment of creativity and collaboration, Moon Surgical ensures that it can consistently deliver cutting-edge solutions that meet the evolving needs of the healthcare industry.

You can follow our news on our Telegram and LinkedIn accounts.

Maestro System Enhances Surgical Practices with AI and Real-Time Data Integration

The Maestro System is designed to support surgeons, operating room staff, and patients in the 18.8 million annual soft tissue surgical procedures not currently supported by available telerobotic systems. Its small, adaptable design integrates seamlessly into existing clinical workflows for any laparoscopic indication, boosting operating room efficiency and providing shorter, more predictable procedure durations. This adaptability is crucial in modern healthcare environments, where efficiency and precision are paramount.

Equipped with NVIDIA Holoscan, the Maestro System uses a powerful edge computing platform that allows real-time algorithms based on artificial intelligence to be deployed in the operating room. This advanced technology provides immediate benefits during surgery, enhancing the overall surgical experience. The ability to process and analyze data in real time ensures that surgeons have the information they need to make informed decisions quickly and accurately.

“The team at Moon Surgical has been impressively delivering on schedule while adding resources to get ready for its commercial phase,” commented Fred Moll, Chair of the Moon Surgical board. “After a fantastic initial experience in Europe in a real-world, multi-specialty setting, we are eager to implement Maestro programs at select US sites over the next few months.” This statement underscores the company’s commitment to expanding its innovative solutions and improving surgical outcomes on a global scale.

 

Resource: PR Newswire, June 05, 2024

Subscribe to our newsletter

To be updated with all the latest news, offers and special announcements.

Latest article